Ensysce Biosciences Statistics
Total Valuation
ENSC has a market cap or net worth of $2.43 million. The enterprise value is $1.93 million.
Important Dates
The last earnings date was Friday, May 15, 2026, after market close.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENSC has 9.28 million shares outstanding. The number of shares has increased by 310.98% in one year.
| Current Share Class | 9.28M |
| Shares Outstanding | 9.28M |
| Shares Change (YoY) | +310.98% |
| Shares Change (QoQ) | +85.34% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 9.69% |
| Float | 9.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.52 |
| Forward PS | 0.42 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -628.42 |
Financial Efficiency
Return on equity (ROE) is -1,149.11% and return on invested capital (ROIC) is -579.10%.
| Return on Equity (ROE) | -1,149.11% |
| Return on Assets (ROA) | -218.22% |
| Return on Invested Capital (ROIC) | -579.10% |
| Return on Capital Employed (ROCE) | 1,769.13% |
| Weighted Average Cost of Capital (WACC) | 8.52% |
| Revenue Per Employee | $470,788 |
| Profits Per Employee | -$1.18M |
| Employee Count | 10 |
| Asset Turnover | 1.39 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.22% in the last 52 weeks. The beta is 0.82, so ENSC's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -88.22% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 32.48 |
| Average Volume (20 Days) | 5,383,401 |
Short Selling Information
The latest short interest is 814,605, so 8.78% of the outstanding shares have been sold short.
| Short Interest | 814,605 |
| Short Previous Month | 52,730 |
| Short % of Shares Out | 8.78% |
| Short % of Float | 8.79% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, ENSC had revenue of $4.71 million and -$11.79 million in losses. Loss per share was -$3.01.
| Revenue | 4.71M |
| Gross Profit | -5.67M |
| Operating Income | -11.84M |
| Pretax Income | -11.79M |
| Net Income | -11.79M |
| EBITDA | n/a |
| EBIT | -11.84M |
| Loss Per Share | -$3.01 |
Full Income Statement Balance Sheet
The company has $745,482 in cash and $245,849 in debt, with a net cash position of $499,633 or $0.05 per share.
| Cash & Cash Equivalents | 745,482 |
| Total Debt | 245,849 |
| Net Cash | 499,633 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | -669,012 |
| Book Value Per Share | -0.04 |
| Working Capital | -828,275 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$9.60 million and capital expenditures -$123,643, giving a free cash flow of -$9.72 million.
| Operating Cash Flow | -9.60M |
| Capital Expenditures | -123,643 |
| Depreciation & Amortization | 13,066 |
| Net Borrowing | -233,006 |
| Free Cash Flow | -9.72M |
| FCF Per Share | -$1.05 |
Full Cash Flow Statement Margins
Gross margin is -120.42%, with operating and profit margins of -251.40% and -250.36%.
| Gross Margin | -120.42% |
| Operating Margin | -251.40% |
| Pretax Margin | -250.37% |
| Profit Margin | -250.36% |
| EBITDA Margin | n/a |
| EBIT Margin | -251.40% |
| FCF Margin | n/a |